
Brii Biosciences develops therapies for infectious and central nervous system diseases with patient-centric approach.
This leadership role will collaborate closely with multiple R&D functional areas to support DMPK needs for both clinical and preclinical programs, enabling decision making for advancement of both drug discovery and development projects.
Brii Biosciences develops therapies for infectious and central nervous system diseases with patient-centric approach.